06Feb 2025
No Clear Best Drug for Episodic Migraine Prevention

No Clear Best Drug for Episodic Migraine Prevention

A review of 61 trials (20,680 patients) assessed 16 pharmacologic treatments for episodic migraine prevention. CGRP-mAbs likely led to fewer discontinuations due to adverse events than topiramate and may reduce migraine-related disability more than gepants. However, no treatment was clearly superior overall. Most comparisons had low- or moderate-certainty evidence, with limited head-to-head trials.

  • #family health

Like

Save

Share